Form 8-K - Current report:
SEC Accession No. 0000950170-22-011164
Filing Date
2022-06-03
Accepted
2022-06-03 16:20:36
Documents
13
Period of Report
2022-06-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srpt-20220602.htm   iXBRL 8-K 130037
2 EX-10.1 srpt-ex10_1.htm EX-10.1 10640
  Complete submission text file 0000950170-22-011164.txt   260237

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srpt-20220602.xsd EX-101.SCH 2484
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srpt-20220602_pre.xml EX-101.PRE 9451
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srpt-20220602_lab.xml EX-101.LAB 12798
7 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20220602_htm.xml XML 4527
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 22994734
SIC: 2834 Pharmaceutical Preparations